I now have comprehensive, detailed information from authoritative veterinary sources (MSD Veterinary Manual 2024, AVMA Journal 2024, Today's Veterinary Practice 2024). Let me compile the complete treatment guide.
Pancreatitis in Dogs and Cats: Complete Clinical Guide
Overview
Pancreatitis is the most common exocrine pancreatic disorder in both dogs and cats. It results from premature activation of digestive enzymes within the pancreas, causing autodigestion and inflammation. Severity ranges from mild/subclinical to necrotizing/life-threatening.
PART 1 - CLINICAL SIGNS AND SYMPTOMS
Dogs
| Severity | Signs |
|---|
| Mild | Anorexia, lethargy, mild diarrhea, vague abdominal discomfort |
| Moderate | Vomiting (often repeated), abdominal pain, dehydration, depression |
| Severe | Cranial abdominal pain ("prayer posture" - elbows down, hindquarters raised), profuse vomiting, severe dehydration, weakness, fever, icterus, tachycardia, tachypnea, shock |
Prayer posture - the classic sign: front legs lowered, rear elevated - is a direct indicator of cranial abdominal pain. Some stoic dogs show only restlessness, trembling, reluctance to move, or vocalization.
Cats
Feline signs are less specific and more subtle than dogs:
- Anorexia (most common)
- Lethargy/depression
- Dehydration
- Weight loss
- Hypothermia (more common than fever in cats)
- Vomiting (less frequent than in dogs)
- Icterus (jaundice)
- Abdominal pain (often occult)
- Palpable abdominal mass (rare)
Key difference: Cats rarely show the dramatic vomiting and "prayer posture" seen in dogs. Many cats with pancreatitis present with only lethargy and anorexia. Also, cats commonly have concurrent triaditis - pancreatitis + cholangitis + inflammatory bowel disease occurring together.
PART 2 - DIAGNOSIS
Step 1: History and Physical Exam
- Diet history (high-fat meal trigger in dogs)
- Drug history: phenobarbital, potassium bromide, L-asparaginase, azathioprine can cause pancreatitis
- Assess dehydration, pain score (modified Glasgow scale), body condition
Step 2: Bloodwork
- CBC: Leukocytosis (neutrophilia), possible anemia
- Biochemistry: Elevated ALT/AST, hyperbilirubinemia, azotemia (pre-renal), hyperglycemia, hypoalbuminemia, hyperlipidemia
- Electrolytes: Hypokalemia, hyponatremia common
Step 3: Lipase Testing (GOLD STANDARD)
- Dogs: Spec cPL (specific canine pancreatic lipase) - >400 mcg/L confirms pancreatitis; 200-400 mcg/L = equivocal. SNAP cPL for in-clinic screening.
- Cats: Spec fPL - >12 mcg/L suggests pancreatitis; >28 mcg/L confirms pancreatitis. SNAP fPL for in-clinic screening.
Step 4: Imaging
- Abdominal radiographs: Decreased contrast in cranial abdomen, "ground glass" appearance, duodenal displacement (dogs); usually normal (cats)
- Abdominal ultrasound: Preferred - hypoechoic pancreas, hyperechoic peripancreatic fat, free fluid, pancreatic enlargement
PART 3 - SEVERITY ASSESSMENT
Mild/Moderate (Outpatient or Short Hospitalization):
- Eating or able to eat with minimal support
- Mild dehydration only
- Spec cPL mildly to moderately elevated
- No systemic complications
Severe (Requires ICU Hospitalization):
- Profuse vomiting, unable to eat
- Moderate to severe dehydration
- Evidence of SIRS (2 or more: tachycardia/bradycardia, tachypnea, hypothermia/hyperthermia, abnormal WBC)
- Organ dysfunction (azotemia, hyperbilirubinemia, coagulopathy)
- Hypotension, shock
PART 4 - STEP-BY-STEP TREATMENT PROTOCOL
STEP 1: FLUID THERAPY (First Priority)
Goal: Correct dehydration, restore pancreatic microcirculation, replace ongoing losses.
Fluid of choice: Isotonic crystalloids
- Lactated Ringer's Solution (LRS) - preferred
- 0.9% NaCl - use if hyperkalemia present
- Plasmalyte - alternative isotonic option
Dosing:
- Calculate % dehydration (clinical estimate):
- 5% = mild skin tenting, tacky mucous membranes
- 8-10% = significant skin tenting, dry MM, sunken eyes
- 12% = extreme skin tenting, shock signs
- Deficit (L) = body weight (kg) x % dehydration
- Replace deficit over 4-8 hours (if no cardiac contraindication)
- Add maintenance: ~60 ml/kg/day (dogs), ~40-50 ml/kg/day (cats)
- Add ongoing losses from vomiting/diarrhea
Hypovolemic shock protocol:
- Dogs: 10-20 ml/kg IV crystalloid bolus, reassess, repeat up to 90 ml/kg total
- Cats: 5-10 ml/kg IV bolus (cats are more sensitive - avoid fluid overload)
Monitoring: Heart rate, blood pressure, urine output (target >1 ml/kg/hr), lung sounds (avoid overhydration)
Current evidence supports moderate fluid resuscitation - give boluses only in response to hypovolemia indicators, not aggressive volume loading, to reduce fluid overload risk.
Colloids (Hetastarch/Hydroxyethyl starch): 5-10 ml/kg/day if hypoproteinemia (albumin <2 g/dL) or oncotic support needed.
STEP 2: ANALGESIA (Treat Aggressively - Do Not Undertreat)
Abdominal pain should be assumed present in all cases until proven otherwise.
Mild to Moderate Pain:
| Drug | Species | Dose | Route | Frequency |
|---|
| Buprenorphine (partial mu-opioid) | Dogs & Cats | 5-30 mcg/kg | IV, IM, SC, or OTM (oral transmucosal in cats) | Every 4-6 hours |
| Butorphanol (kappa-opioid, mild) | Dogs & Cats | 0.2-0.4 mg/kg | IV, IM, SC | Every 4 hours as needed |
| Meperidine (Pethidine) | Dogs & Cats | 3-5 mg/kg | IM or SC only | Every 2 hours as needed |
Note: Buprenorphine via OTM (oral transmucosal) is highly effective in cats - place under tongue or on oral mucosa.
Severe Pain - CRI (Continuous Rate Infusion):
| Drug | Loading Dose | CRI Dose | Notes |
|---|
| Morphine | 0.3-0.5 mg/kg IV slowly | 0.1-1 mg/kg/h IV CRI | Dogs mainly; avoid in cats (histamine release) |
| Fentanyl | 2-10 mcg/kg IV | 2-10 mcg/kg/h IV CRI | Both species; preferred in cats |
| Methadone | 0.1-0.2 mg/kg IV loading | 0.12 mg/kg/h IV CRI | Good option; also mu-opioid |
| Hydromorphone | 0.1-0.2 mg/kg IV/IM/SC | - | Intermittent; suitable mild-moderate |
Adjunct Analgesia (CRI add-ons for refractory pain):
| Drug | Dose | Notes |
|---|
| Ketamine | 4 mg/kg IV bolus + 2-10 mcg/kg/min CRI | NMDA antagonist; opioid-sparing; use sub-anesthetic doses |
| Lidocaine | 2-4 mg/kg IV bolus (slowly) + 2-4 mg/kg/h CRI | Dogs only; NOT cats (cats are lidocaine-toxic at systemic doses); reduces opioid requirements |
Avoid NSAIDs (meloxicam, carprofen, etc.) - contraindicated due to GI adverse effects, risk of AKI in dehydrated patients, and impaired pancreatic perfusion.
STEP 3: ANTI-EMETICS
First-Line:
| Drug | Species | Dose | Route | Frequency | Mechanism |
|---|
| Maropitant (Cerenia) | Dogs & Cats | 1 mg/kg IV or SC; 2 mg/kg PO | IV, SC, PO | Every 24 hours | NK1 receptor antagonist; also has visceral analgesic properties |
| Ondansetron | Dogs & Cats | 0.1-0.5 mg/kg | IV (slowly), PO | Every 8-12 hours | 5-HT3 antagonist; good for vomiting refractory to maropitant |
Second-Line:
| Drug | Species | Dose | Notes |
|---|
| Dolasetron | Dogs & Cats | 0.6 mg/kg IV | 5-HT3 antagonist; alternative to ondansetron |
| Metoclopramide | Dogs | 0.2-0.5 mg/kg PO/SC/IM TID, or 1-2 mg/kg/day CRI | Use cautiously - dopamine antagonist that may impair pancreatic perfusion; avoid as first-line |
Maropitant is the preferred first-line antiemetic for both dogs and cats. It also provides some visceral analgesic benefit.
STEP 4: NUTRITIONAL SUPPORT
Old approach (ABANDONED): "Gut rest" - NPO (nothing by mouth) for 24-72 hours.
Current evidence-based approach: Early enteral nutrition as soon as the patient can tolerate it.
Why early feeding?
- Prolonged NPO causes mucosal atrophy, enterocyte apoptosis, gut barrier dysfunction, and bacterial translocation
- Early enteral feeding is well tolerated and leads to earlier voluntary food intake and fewer GI complications
Dogs - Feeding Protocol:
- Mild pancreatitis: Offer small amounts of low-fat diet (< 20 g fat per 1,000 kcal) within 24 hours
- Moderate/severe pancreatitis with vomiting: Once vomiting is controlled (24-48h), attempt oral feeding of low-fat diet in small frequent meals (4-6 x/day)
- Cannot eat voluntarily: Place a nasoesophageal (NE) tube or esophagostomy tube for assisted enteral nutrition
- Appetite stimulants: Capromorelin (Entyce) 3 mg/kg PO every 24 hours
Avoid high-fat treats, table scraps, or any fatty food during treatment and recovery.
Cats - Feeding Protocol:
- Cats MUST eat to avoid hepatic lipidosis - feeding is urgent
- Offer hydrolyzed protein diet (moderate fat restriction, not strict low-fat like in dogs)
- Appetite stimulants:
- Mirtazapine: 2 mg/cat PO or transdermally every 24 hours (preferred in cats)
- Capromorelin (Elura): 2 mg/kg PO every 24 hours
- If cat refuses food: nasogastric or esophagostomy tube feeding within 48-72 hours
- Treat concurrent triaditis (cholangitis, IBD) simultaneously
STEP 5: ANTIBIOTICS
Not routinely indicated. Pancreatitis is an inflammatory (not primary infectious) process.
Indications for antibiotics:
- Confirmed aspiration pneumonia
- Evidence of septic peritonitis
- Documented bacterial infection (culture-positive)
- Suspicion of gastrointestinal bacterial translocation (severe, necrotizing pancreatitis with sepsis signs)
- Pancreatic abscess
Antibiotic choices (when indicated):
| Drug | Dose | Route | Frequency | Notes |
|---|
| Ampicillin-sulbactam | 22 mg/kg | IV | Every 8 hours | Broad-spectrum; first-line for septic patients |
| Metronidazole | 10-15 mg/kg | IV, PO | Every 12 hours | Anaerobic coverage; add-on for gut translocation |
| Enrofloxacin | Dogs: 5-10 mg/kg; Cats: 5 mg/kg | IV, PO | Every 24 hours | Cats: do NOT exceed 5 mg/kg/day - retinal toxicity risk |
| Amoxicillin-clavulanate | 12.5-25 mg/kg | PO | Every 12 hours | For mild cases/outpatient when antibiotics needed |
STEP 6: SPECIFIC TARGETED THERAPY (DOGS ONLY)
Fuzapladib Sodium (Panoquell-CA1) - NEW FDA-Conditionally Approved
- Mechanism: LFA-1 inhibitor - blocks neutrophil extravasation into inflamed tissue, reducing early inflammatory cascade
- Indication: Acute-onset pancreatitis in dogs
- Dose: 0.4 mg/kg IV every 24 hours for 3 days
- Species: Dogs only (no feline approval)
- Status: FDA conditional approval (US) and licensed in Japan; reasonable expectation of effectiveness based on pilot studies
STEP 7: ADDITIONAL / SUPPORTIVE MEDICATIONS
Proton Pump Inhibitors (PPIs):
- Not routinely recommended for pancreatitis unless specific indication (gastric ulceration, reflux esophagitis)
- Omeprazole: 1 mg/kg PO every 12-24 hours (dogs); 0.7 mg/kg PO every 24 hours (cats) - if indicated
- Pantoprazole: 1 mg/kg IV every 24 hours - IV option when PO not possible
Prokinetics (for GI ileus):
- Cisapride: 0.1-0.5 mg/kg PO every 8 hours - helps gastric emptying, esophageal sphincter tone; good for reflux esophagitis
- Erythromycin: 0.5-1 mg/kg PO/IV every 8 hours - low-dose prokinetic (motilin agonist)
- Use after adjusting opioid dose if ileus is suspected
Plasma/Fresh Frozen Plasma:
- Not routinely recommended
- Consider only in documented DIC (disseminated intravascular coagulation) or severe hypoproteinemia
Corticosteroids:
- Not routinely recommended for dogs
- Reserve for: Vasopressor-refractory hypotension, or when conventional therapy fails after ruling out contraindications
- Cats with chronic pancreatitis: Prednisolone 1-2 mg/kg PO every 24 hours, taper over weeks-months (cats are more responsive to immunosuppression); cyclosporine is an alternative per 2022 ACVIM data
- Dexamethasone for shock doses in critical patients: 0.1-0.2 mg/kg IV once
Electrolyte Supplementation:
- Potassium chloride (KCl): Add to IV fluids based on serum K+:
- K+ 3.0-3.5: add 20 mEq/L
- K+ 2.5-3.0: add 30 mEq/L
- K+ 2.0-2.5: add 40 mEq/L
- K+ < 2.0: add 60 mEq/L (do not exceed 0.5 mEq/kg/h infusion rate)
- Phosphorus: Supplement if hypophosphatemia detected
Vitamin B12 (Cobalamin):
- Cats frequently develop cobalamin deficiency with pancreatitis/IBD
- Cyanocobalamin: 250 mcg SC every 7 days for 4-6 weeks, then monthly
- Dogs: 250-1500 mcg SC weekly depending on weight
STEP 8: MANAGEMENT OF UNDERLYING CAUSES
| Risk Factor | Action |
|---|
| Hypertriglyceridemia | Low-fat diet; fenofibrate may be added |
| Hypercalcemia | Identify cause (lymphoma, hyperparathyroidism, vitamin D toxicity); treat accordingly |
| Drugs | Discontinue phenobarbital, azathioprine, L-asparaginase, or other suspected triggers if possible |
| Diabetes mellitus | Concurrent management; insulin regulation post-pancreatitis |
| Hypothyroidism (dogs) | Thyroid supplementation |
| Concurrent triaditis (cats) | Treat IBD and cholangitis simultaneously |
PART 5 - MONITORING DURING TREATMENT
| Parameter | Frequency | Target |
|---|
| Body weight | Every 12-24h | Stable; no fluid overload |
| Urine output | Continuous/hourly (ICU) | > 1-2 ml/kg/hour |
| Blood pressure | Every 4-8h | MAP > 70 mmHg |
| Heart rate | Every 4-6h | Dogs: 60-140; Cats: 140-200 |
| Pain score | Every 4-6h | Reassess and adjust analgesia |
| Electrolytes | Every 12-24h | Correct K+, Na+, phosphorus |
| Blood glucose | Every 4-12h | Monitor for transient hyperglycemia or hypoglycemia |
| PCV/TP | Every 12-24h | Trend for improvement in hydration |
| Spec cPL / Spec fPL | Every 3-5 days | Trending toward normal |
PART 6 - SPECIAL CONSIDERATIONS: DOGS vs CATS SUMMARY
| Feature | Dogs | Cats |
|---|
| Vomiting | Prominent, repeated | Mild or absent |
| Pain posture | Prayer posture classic | Occult pain |
| Diagnostic test | Spec cPL (>400 mcg/L) | Spec fPL (>28 mcg/L) |
| Diet | Strict low-fat (< 20 g fat/1000 kcal) | Moderate fat restriction; hydrolyzed protein |
| Lidocaine CRI | Yes, safe | Contraindicated (systemic toxicity) |
| Appetite stimulant | Capromorelin 3 mg/kg/day | Mirtazapine 2 mg/cat/day or Capromorelin 2 mg/kg/day |
| Fuzapladib | FDA-approved | Not approved |
| Chronic form | Less common | More common (chronic low-grade) |
| Concurrent disease | DM, hyperlipidemia, hypothyroidism | Triaditis (IBD + cholangitis + pancreatitis) |
| Steroid use | Rarely, refractory only | More common; prednisolone for chronic cases |
PART 7 - DISCHARGE AND LONG-TERM MANAGEMENT
- Continue low-fat diet (dogs) or hydrolyzed/moderate-fat diet (cats) long-term
- Oral antiemetics (maropitant 2 mg/kg PO once daily) for 5-7 days if vomiting
- Analgesia: Buprenorphine OTM for cats (5-20 mcg/kg every 8 hours) for mild ongoing pain at home; oral tramadol 2-5 mg/kg every 8-12 hours as additional option
- Recheck Spec cPL/fPL in 2-4 weeks
- Monitor for complications: Diabetes mellitus (post-pancreatitis), exocrine pancreatic insufficiency (EPI), pancreatic pseudocyst
- Avoid high-fat diets, treats, table scraps permanently in dogs with recurrent pancreatitis
- Cats: Monitor for and manage triaditis long-term; cobalamin supplementation if indicated
Quick Drug Dosage Reference Card
| Drug | Dog Dose | Cat Dose | Route |
|---|
| Maropitant | 1 mg/kg IV/SC or 2 mg/kg PO q24h | 1 mg/kg IV/SC q24h | IV/SC/PO |
| Ondansetron | 0.1-0.5 mg/kg q8-12h | 0.1-0.2 mg/kg q8-12h | IV/PO |
| Buprenorphine | 5-30 mcg/kg q4-6h | 5-20 mcg/kg q4-8h OTM | IV/IM/SC/OTM |
| Fentanyl CRI | 2-10 mcg/kg loading + 2-10 mcg/kg/h | 2-5 mcg/kg loading + 2-5 mcg/kg/h | IV CRI |
| Methadone | 0.1-0.2 mg/kg loading q4-6h | 0.1-0.2 mg/kg q6-8h | IV/IM |
| Ketamine CRI | 4 mg/kg bolus + 2-10 mcg/kg/min | 2 mg/kg bolus + 2-5 mcg/kg/min | IV CRI |
| LRS / Crystalloids | Deficit + maintenance | Deficit + maintenance | IV |
| KCl supplementation | Based on K+ level | Based on K+ level | IV (in fluids) |
| Capromorelin | 3 mg/kg q24h | 2 mg/kg q24h | PO |
| Mirtazapine | 1.88 mg/dog q24-48h | 2 mg/cat q24h (or transdermal) | PO/transdermal |
| Fuzapladib | 0.4 mg/kg q24h x 3 days | Not approved | IV |
| Prednisolone | Reserve/refractory | 1-2 mg/kg q24h (chronic) | PO |
| Ampicillin-sulbactam | 22 mg/kg q8h | 22 mg/kg q8h | IV |
| Metronidazole | 10-15 mg/kg q12h | 10-15 mg/kg q12h | IV/PO |
| Vitamin B12 | 250-1500 mcg q7 days | 250 mcg q7 days | SC |
| Omeprazole | 1 mg/kg q12-24h | 0.7 mg/kg q24h | PO |
Disclaimer: This guide is intended for qualified veterinary professionals. All drug doses should be verified against current formularies and adjusted based on individual patient assessment, body weight, organ function, and clinical response. Consult a board-certified veterinary internist for complex or refractory cases.